PETS
PETMED EXPRESS INC
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$1.61
−0.62%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.60
From 52W high−58.72%
Volume254204.00
Market cap$34.90M
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataSep 18, 2026
Open
$1.60
From 52W high
−58.72%
Volume
254204.00
Market cap
$34.90M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
P/E (TTM)
—
RSI (14)
31.2
MomentumView details →
1D Return
−0.62%
YTD Return
−49.84%
SummaryUpdated Jun 1, 2026
PetMed Express, Inc. (NASDAQ:PETS) is a pet pharmacy company founded in 1996 and headquartered in Delray Beach, Florida. The company went public in 1999 and operates as one of the leading direct-to-consumer pet medication and health product retailers in the United States. Over its nearly three-decade history, PetMed Express has evolved from a traditional mail-order pharmacy to a multi-channel digital platform serving pet owners nationwide. The company has undergone significant transformation in recent years, including the acquisition and integration of PetCareRx, positioning itself as a comprehensive pet health and wellness provider beyond just prescription medications.
Similar companies
Latest newsMore news →
Peter Batushansky became Chair of the Corporate Governance and Nominating Committee of PetMed Express Inc., effective September 28, 2026.3d agoPetMed Express Inc. elected Justin Mennen as Chair of the Board, effective September 28, 2026.3d agoLeslie C.G. Campbell retired from the PetMed Express Inc. board and resigned as Interim Chief Executive Officer and President, effective September 28, 2026.3d ago